India’s CDMO sector is rapidly expanding, driven by global pharma’s shift away from China, strong regulatory compliance, cost-efficiency, and government…
While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…
